July 09, 2026
The smart healthcare market is expected to rise from USD 397.98 billion in 2026 to USD 1833.7 billion by 2035,...
Read MoreJuly 24, 2026
The blood pressure measuring devices market is expected to see growth from USD 2.08 billion in 2026 to USD 4.5...
Read MoreJanuary 21, 2026
The medical device CMO and CDMO market is expected to see growth from USD 52.57 billion in 2026 to USD 110.82 ...
Read MoreJune 04, 2026
The simulators market size is forecast to increase from USD 14.71 billion in 2026 to USD 27.59 billion by 2035...
Read MoreApril 21, 2026
According to forecasts, the global kidney organ-on-a-chip market will grow from USD 192 million in 2024 to USD 1314.52 million by 2034, with an expected CAGR of 21.27%. A rise in CKD cases and advances in materials are fueling the global market. North America led the market due to rising focus on drug discovery and toxicity testing....
April 21, 2026
The global AAV vector CDMO services market was valued at USD 9.84 billion in 2024 and is projected to reach USD 25.36 billion by 2034, growing at a CAGR of 9.75%. North America led with 38% share, followed by Europe (29%) and Asia-Pacific (23%). The report covers service type, container format, scale, and end-user segments, along with value chain, ...
April 21, 2026
The smart clinic market will grow from USD 2.97 billion in 2025 to USD 10.88 billion by 2034 at a CAGR of 15.47%, driven by rising adoption of AI, IoT, and telehealth technologies. The report includes segmentation by component, technology, application, and end-user, with North America holding a 38.5% share and Asia-Pacific showing the fastest growt...
April 21, 2026
According to market projections, the global generic drug CRO market, valued at USD 8.45 billion in 2024, is anticipated to reach USD 11.73 billion by 2034, growing at a CAGR of 3.36% over the next decade. The generic drug CRO market is growing due to increasing demand for affordable healthcare services and the expiration of patents on major medicin...
April 21, 2026
Based on market forecasts, the global lead optimization services in drug discovery market, projected at USD 4.26 billion in 2024, is expected to reach USD 10.26 billion by 2034, growing at a CAGR of 9.23% over the forecast period. The lead optimization services in drug discovery market is expanding due to the growing outsourcing of medicinal chemis...
April 21, 2026
Market insights predict, the ADC outsourcing service industry is expected to grow from USD 2.76 billion in 2024 to USD 5.19 billion by 2034, driven by a CAGR of 6.52%. The growing demand for targeted therapeutics and increasing R&D investments bolster market growth. North America dominated the global market owing to the presence of key players ...
April 21, 2026
Market insights predict the global oncolytic virus CDMO services industry will increase from USD 419.51 million in 2025 to USD 1734.41 million by 2035, achieving a CAGR of 15.25%. Rising cancer prevalence globally, increasing demand for innovative therapies. North America led the global market owing to the presence of leading CDMO players and contr...
April 21, 2026
Projections indicate that, innovative drug CRO industry is projected to rise from USD 56.56 billion in 2025 to USD 96.06 billion by 2035, reflecting a CAGR of 5.44% over the next decade. The growing demand for personalized medicines and technological advancements drives the global market. North America led the market owing to the presence of key pl...
April 21, 2026
Projections indicate that, the global AAV manufacturing service market will increase from USD 1.44 billion in 2025 to USD 6.25 billion by 2035, experiencing a CAGR of 15.84% over the next 10 years. The critical importance of adeno-associated virus for gene therapies drives the need for its production processes. North America dominated the market in...
April 21, 2026
Market insights predict, the cell culture collagen industry is expected to grow from USD 2.31 billion in 2024 to USD 4.19 billion by 2034, driven by a CAGR of 6.15%. The Cell Culture Collagen Market is growing due to rising demand for cell and gene therapies and advancements in regenerative medicine. North America is dominant in the market due to�...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
